Most Recent
‘I just don’t get it’: judge questions Sandoz cross claim in Lexapro patent case
A Federal Court judge has expressed her disbelief at a cross claim by generic drug maker Sandoz against Danish multinational H Lundbeck, as the court begins to weigh arguments over damages owed to Lundbeck in the long-running patent case over its blockbuster anti-depressant Lexapro.
Merck Sharp & Dohme, Wyeth gear up for trial over vaccine patents
Preparations for a December trial between Merck Sharp & Dohme Corporation and Wyeth over four patents for the pneumococcal disease vaccine are underway, and a panel of experts will feature prominently in the high-stakes hearing over the world's best-selling vaccine.
Broker can’t take back admission in Provident class action defence
A judge has shot down a last minute bid by an insurance brokerage facing a cross claim in a class action over failed debenture issuer Provident Capital to retract an admission in its defence ahead of trial next month.
Competing Murray Goulburn class actions look set to co-exist
The judge presiding over two shareholder class actions against Murray Goulburn indicated Friday he would likely let both cases proceed jointly to a trial in 2020.
Hastie liquidators battle major builders over millions in unpaid bills
Liquidators for failed engineering services company Hastie Group have a fight on their hands over tens of millions of dollars in unpaid invoices from construction companies, with major builders claiming not only that they don't have to pay, but that the bills aren't payable.
QRxPharma defendants can access class members’ broker details
The defendants in a shareholder class action over QRxPharma's alleged failure to disclose problems with regulatory approval for its painkiller Moxduo have won access to information on class members' financial brokers.
Codeine patents involve natural parts that can’t be patented, court told
TPI Enterprises has gone on the offensive in a patent lawsuit initiated by rival poppy processor Tasmanian Alkaloids, saying the patents at the centre of the suit describe natural parts that can't be patented.
Cryosite hits back at ACCC ‘gun jumping’ claims
Biologics company Cryosite has denied claims by the ACCC that it engaged in cartel conduct by referring customers to Cell Care before their asset sale agreement was completed, saying the two were not competitors.
Murray Goulburn, ex-boss close to settling ACCC case
Murray Goulburn and its former CEO appear to be nearing a settlement with the consumer watchdog over claims the dairy producer misled farmers in three states about farmgate milk prices.
Judge calls out law firm for ‘threatening’ letters in Targus dispute
Letters by law firm Corrs Chambers Westgarth for its client amid a contractual and consumer law dispute between two technology companies has been described by a judge as "bullying" and "threatening".